Loading Shopping Cart Items...
Sponsored by The Binding Site
FREE FOR MEMBERS!
Description: The serum FLC assay is a quantitative and fully automated approach to measure free lambda and free kappa light chain levels in the serum. With more than 3000 articles published so far, this assay has been proven as being a major breakthrough for the diagnosis and monitoring of multiple myeloma and other monoclonal gammopathies. In conjunction with other methods used in the diagnosis of these malignancies, the serum Free Light Chain assay is now part of the battery of tests recommended by all guidelines for diagnosis, monitoring and prognosis. However, knowing limitations and how to interpret results on the Optilite instrument are keys for an optimal utilization of the assay and result reporting.
Date: November 30, 2023
Time: 12pm – 1pm (ET)
At the end of this session you will be able to:
Speaker: Frank Courjal, PhD
Frank Courjal, Ph.D. received his doctoral degree in biochemistry and molecular biology from the University of Montpellier in France. He evolved in the field of oncology for more than 30 years as postdoctoral fellow in Quebec, Canada, or Director of Development in biotech or large diagnosis companies developing anti-cancer molecules and FDA approved PCR based assays or as Medical Science Liaison in the pharmaceutical industry.
He joined The Binding Site 12 years ago as Director of Scientific Affairs for Canada and often gives lectures pertinent to the most recent updates to the international myeloma guidelines and the clinical utility of serum free light chain assays.
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.